07 Jan 2001

Becozyme c - España

Updated: 07 Jan 2001

Becozyme c forte 30 grageas

Profilaxis de estados carenciales de vitaminas del grupo B y vitamina C: Restricciones dietéticas, malabsorción, tratamiento.

Becozyme c Description, Presentation and Dosage

Becozyme c Description

Becozyme c Drug Class Description

Complejo b, otras asociaciones

Becozyme c Drug Description


Becozyme c Presentation

Becozyme c Presentation

Dosis usual: 1-3 grageas al día.

Becozyme c Manufacturer


Related Learning Zones

Anti-Coagulation Video Channel

Anti-Coagulation Video Channel

The Anti-Coagulation Video Channel is regularly updated with expert videos discussing how to prevent stroke and systemic embolism in non-valvular atrial fibrillation (AF) patients and how to prevent and treat venous thromboembolism (VTE). This free resource is intended for primary care practitioners and specialists involved in the treatment and follow up care of patients with AF or VTE.

This resource has been developed in collaboration with Boehringer Ingelheim.

Type 2 Diabetes

Type 2 Diabetes

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Becozyme c Dosage

Becozyme c Precautions, Reactions and Contraindications

Becozyme c Special Precautions

Related Drugs - Gastroenterologia

Back to top